At Clariti, we offer a wide range of Cancer Genes and Panels.
After reviewing NCCN guidelines, professional recommendations, and scientific literature, we designed our test panel to include 37 genes that are associated with increased predisposition to cancer.
We offer the most up-to-date hereditary cancer testing. We are the only lab in the US that includes BRCA1 and BRCA2 promoters in our test offerings. The latest research has demonstrated the importance of these promoters in cancer heritability*.
*Gareth D, et al., A Dominantly Inherited 5’ UTR Variant Causing Methylation-Associated Silencing of BRCA1 as a Cause of Breast and Ovarian Cancer, The American Journal of Human Genetics 103, 213-220, August 2, 2018